Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients

Prospective multicentric study to evaluate the compliance of gastroprotective treatment in NSAID patients at risk of GI complications. Secondary objectives: To identify the factors associated to treatment compliance (both NSAID and PPI), to evaluate the relationship between compliance and NSAID-associated GI events

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Compliance Behavior Gastroprotector Therapy Health Behavior Patient Acceptance of Health Care Patient Compliance Risk Factors Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Vitoria-Gasteiz, Alava, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Signed informed consent
Patients consulting to the specialized care clinics who have been prescribed NSAID and gastroprotection for at least 15 days following standard clinical practice.

Exclusion criteria

Any gastroprotective treatment prescribed for other condition than NSAID-related gastrointestinal event prevention

Treatment and study plan

Primary outcomes

Adherence to gastroprotection treatment

Time frame: End of follow-up (3-5 weeks)

Secondary outcomes

Identify factors associated with treatment compliance

Time frame: End of follow-up
Evaluate the relationship among GI events and treatment compliance

Time frame: End of follow-up

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Compliance of Gastroprotection Treatment in the Prevention of Gastrointestinal Risk in Non-Steroidal Anti-inflammatory Drug (NSAID) Using Patients

Acronym: GADES

Important dates

Study start: 2008
Primary completion: 2009
Study completion: 2009
First posted: Jun 18, 2008
Registry last updated: Dec 7, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed